Viking Therapeutics Stock: Can VK2735 Beat Wegovy & Zepbound?

Is Viking Therapeutics the Next Blockbuster GLP-1 Stock? Written by Jea Yu | Reviewed by Shannon Tokheim March 18, 2025 Share Link copied to clipboard. Key Points Viking’s VK2735 GLP-1 drug has shown 13.1% placebo-adjusted weight loss in ju
Read more...